Advertisement

Topics

M&As this week: Gilead Sciences, RegenxBio

19:00 EDT 31 Aug 2017 | Net Resources International

Gilead Sciences and its subsidiary Dodgers Merger Sub plan to acquire Kite Pharma for $11.9bn.

Original Article: M&As this week: Gilead Sciences, RegenxBio

NEXT ARTICLE

More From BioPortfolio on "M&As this week: Gilead Sciences, RegenxBio"

Quick Search
Advertisement
 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...